Critical decisions in selecting an intravenous immunoglobulin product.

@article{Gelfand2005CriticalDI,
  title={Critical decisions in selecting an intravenous immunoglobulin product.},
  author={Erwin W. Gelfand},
  journal={Journal of infusion nursing : the official publication of the Infusion Nurses Society},
  year={2005},
  volume={28 6},
  pages={
          366-74
        }
}
Use of intravenous immunoglobulin (IVIG) therapy has expanded enormously in the past two to three decades, targeting a large number of autoimmune and inflammatory disorders as well as primary immunodeficiency disease, human immunodeficiency virus, and Kawasaki disease. Increased use, particularly at higher doses and in older patients, has presented certain challenges related to safety and tolerability. All IVIGs are not the same. They differ in manufacturing processes, methods of virus… CONTINUE READING
BETA

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-9 OF 9 CITATIONS

The nurse's role in administration of intravenous immunoglobulin therapy.

  • Home healthcare nurse
  • 2009
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Nursing guidelines for administration of immunoglobulin replacement therapy.

  • Journal of infusion nursing : the official publication of the Infusion Nurses Society
  • 2013
VIEW 1 EXCERPT
CITES BACKGROUND

Immunoglobulin: production, mechanisms of action and formulations

  • Revista brasileira de hematologia e hemoterapia
  • 2011
VIEW 1 EXCERPT
CITES METHODS

Similar Papers

Loading similar papers…